Impact of investigator financial conflicts of interest and industry sponsorship of clinical trials on patient participation
Braunstein, J.B.; Schulman, S.P.; Powe, N.R.
Circulation 108(17): IV758
2003
ISSN/ISBN: 0009-7322
Accession: 035092953
PDF emailed within 1 workday: $29.90
Related References
Rochon, P.A.; Sekeres, M.; Hoey, J.; Lexchin, J.; Ferris, L.E.; Moher, D.; Wu, W.; Kalkar, S.R.; Van Laethem, M.; Gruneir, A.; Gold, J.; Maskalyk, J.; Streiner, D.L.; Taback, N.; Chan, A-Wen. 2011: Investigator experiences with financial conflicts of interest in clinical trials Trials 12: 9Perlis, R.H.; Perlis, C.S.; Wu, Y.; Hwang, C.; Joseph, M.; Nierenberg, A.A. 2005: Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry American Journal of Psychiatry 162(10): 1957-1960
Gray, S.W.; Hlubocky, F.J.; Ratain, M.J.; Daugherty, C.K. 2007: Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(23): 3488-3494
Perlis, C.S.; Harwood, M.; Perlis, R.H. 2005: Extent and impact of industry sponsorship conflicts of interest in dermatology research Journal of the American Academy of Dermatology 52(6): 967-971
Moraes, F.Ynoe.de.; Leite, E.Trigo.Teixeira.; Hamstra, D.A.; Feng, F.Y.; Arruda, F.Freire.; Gadia, R.; Abreu, C.Eduardo.Cintra.Vita.; Marta, G.Nader.; Hanna, S.Abdallah.; Silva, Jão.Luis.Fernandes.da.; Carvalho, H.de.Andrade.; Spratt, D.E. 2018: Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving Radiotherapy American Journal of Clinical Oncology 41(1): 6-12
Ludwig, W-Dieter.; Hildebrandt, M.; Schott, G. 2009: Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science Zeitschrift für Evidenz Fortbildung und Qualitat Im Gesundheitswesen 103(3): 149-154
Barbarash, R.A.; Miller, C.K.; Corboy, D.L.; Hirlinger, M.A.; Burke, J.M.; Searight, H.R.ssell 1994: Investigator-sponsor financial disclosure during informed consent Patient attitudes and impact on enrollment in clinical trials Pharmacotherapy 14(3): 376
Leite, E.T.T.; Moraes, F.Y.; Marta, G.N.; Taunk, N.K.; Vieira, M.T.L.; Hanna, S.A.; Silva, Jão.Luis.F.; Carvalho, H.A. 2017: Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials Breast 33: 29-33
Raman, S.; Moraes, F.Y.; Mendez, L.C.; Taunk, N.K.; Suh, J.H.; Souhami, L.; Slotman, B.; Kongkham, P.; Spratt, D.E.; Berlin, A.; Marta, G.N. 2018: The relationship of study and authorship characteristics on trial sponsorship and self-reported conflicts of interest among neuro-oncology clinical trials Journal of Neuro-Oncology 139(1): 195-203
Ehrlich, O.; Wingate, L.; Heller, C.; de Melo-Martin, I. 2019: When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest Bmc Medical Ethics 20(1): 96
Kaiser, J. 2002: Clinical trials. Proposed rules aim to curb financial conflicts of interest Science 295(5553): 246-247
Helft, P.R.; Ratain, M.J.; Epstein, R.A.; Siegler, M. 2004: Inside information: Financial conflicts of interest for research subjects in early phase clinical trials Journal of the National Cancer Institute 96(9): 656-661
Williams, K.M. 2004: Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting Food and Drug Law Journal 59(1): 45-77
Barnes, M.; Florencio, P.S. 2003: Investigator, IRB and institutional financial conflicts in interest in human-subject research: past, present and future Seton Hall Law Review 32(3): 525-560
Jia, S.; Brown, D.; Wall, A.; Kodner, I.; Keune, J.D. 2013: Industry-sponsored clinical trials: the problem of conflicts of interest Bulletin of the American College of Surgeons 98(5): 32-35
Tereskerz, P.M.; Moreno, J. 2005: Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research Accountability in Research 12(2): 139-155
Benninger-Döring, G.; Boos, J. 2006: Non-commercial clinical trials--who will be the legal sponsor? Sponsorship of investigator-initiated clinical trials according to the German Drug Law Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49(7): 675-680
Lu, Y; Sharara, N; Jones, D J.; Kaltenbach, T; Martel, M; Barkun, A N. 2015: Su1103 Introducing Non-Financial Conflicts of Interest (COI) and Refining Financial Conflicts of Interest in Consensus Guideline Development Gastroenterology 148(4): S-408-S-409
Ronai, S.E. 2001: Growing public scrutiny of FDA clinical trials: ethical and regulatory compliance to avoid "uninformed consent" and financial conflicts of interest Connecticut Medicine 65(11): 661-666
Lachin, J.M. 2004: Conflicts of interest in data monitoring of industry versus publicly financed clinical trials Statistics in Medicine 23(10): 1519-1521